Provided by Tiger Fintech (Singapore) Pte. Ltd.

Sangamo Therapeutics Inc

0.5376
+0.00260.49%
Volume:1.61M
Turnover:859.56K
Market Cap:127.73M
PE:-1.43
High:0.5417
Open:0.5300
Low:0.5206
Close:0.5350
Loading ...
Aug 04, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
May 25, 2022

Major Issues Report

8-K - Current report
May 05, 2022

Major Issues Report

8-K - Current report
May 05, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 01, 2022

Major Issues Report

8-K - Current report
Mar 28, 2022

Major Issues Report

8-K - Current report
Feb 24, 2022

Major Issues Report

8-K - Current report
Feb 24, 2022

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 10, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 09, 2022

Major Issues Report

8-K - Current report
Jan 06, 2022

Major Issues Report

8-K - Current report
Dec 13, 2021

Major Issues Report

8-K - Current report
Dec 03, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Nov 30, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Nov 03, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Aug 17, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Aug 09, 2021

Statement Of Changes In Beneficial Ownership

3 - Initial statement of beneficial ownership of securities
Aug 05, 2021

Major Issues Report

8-K - Current report
Jul 01, 2021

Major Issues Report

8-K - Current report
May 28, 2021

Major Issues Report

8-K - Current report